Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bio-Techne Corp (TECH : NSDQ)
 
 • Company Description   
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

Number of Employees: 3,100

 
 • Price / Volume Information   
Yesterday's Closing Price: $48.21 Daily Weekly Monthly
20 Day Moving Average: 3,362,958 shares
Shares Outstanding: 156.57 (millions)
Market Capitalization: $7,548.19 (millions)
Beta: 1.41
52 Week High: $72.16
52 Week Low: $43.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -7.64% -12.16%
12 Week -16.76% -23.05%
Year To Date -18.02% -25.95%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
614 MCKINLEY PLACE NE
-
MINNEAPOLIS,MN 55413
USA		 ph: 612-379-8854
fax: 612-656-4400		 ir@bio-techne.com http://www.bio-techne.com
 
 • General Corporate Information   
Officers
Kim Kelderman - President; Chief Executive Officer and Director
Robert V. Baumgartner - Chairman of the Board and Director
James Hippel - Chief Financial Officer
Julie Bushman - Director
Rupert Vessey - Director

Peer Information
Bio-Techne Corp (CORR.)
Bio-Techne Corp (RSPI)
Bio-Techne Corp (CGXP)
Bio-Techne Corp (BGEN)
Bio-Techne Corp (GTBP)
Bio-Techne Corp (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 09073M104
SIC: 2836
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/05/26
Share - Related Items
Shares Outstanding: 156.57
Most Recent Split Date: 11.00 (4.00:1)
Beta: 1.41
Market Capitalization: $7,548.19 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.66%
Current Fiscal Quarter EPS Consensus Estimate: $0.49 Indicated Annual Dividend: $0.32
Current Fiscal Year EPS Consensus Estimate: $1.69 Payout Ratio: 0.18
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: -0.01
Estmated Long-Term EPS Growth Rate: 7.62% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 28.60
Trailing 12 Months: 27.71
PEG Ratio: 3.75
Price Ratios
Price/Book: 3.62
Price/Cash Flow: 19.72
Price / Sales: 6.23
EPS Growth
vs. Year Ago Period: -4.00%
vs. Previous Quarter: 23.08%
Sales Growth
vs. Year Ago Period: -1.51%
vs. Previous Quarter: 5.25%
ROE
03/31/26 - 13.57
12/31/25 - 13.94
09/30/25 - 13.59
ROA
03/31/26 - 10.66
12/31/25 - 10.76
09/30/25 - 10.43
Current Ratio
03/31/26 - 4.49
12/31/25 - 4.54
09/30/25 - 4.22
Quick Ratio
03/31/26 - 3.18
12/31/25 - 3.08
09/30/25 - 2.81
Operating Margin
03/31/26 - 22.36
12/31/25 - 22.68
09/30/25 - 22.29
Net Margin
03/31/26 - 9.05
12/31/25 - 6.67
09/30/25 - 6.41
Pre-Tax Margin
03/31/26 - 12.15
12/31/25 - 9.39
09/30/25 - 8.74
Book Value
03/31/26 - 13.32
12/31/25 - 12.85
09/30/25 - 12.62
Inventory Turnover
03/31/26 - 2.12
12/31/25 - 2.14
09/30/25 - 2.18
Debt-to-Equity
03/31/26 - 0.10
12/31/25 - 0.13
09/30/25 - 0.15
Debt-to-Capital
03/31/26 - 8.75
12/31/25 - 11.45
09/30/25 - 13.24
 

Powered by Zacks Investment Research ©